In the Zhao Breast dataset [21], SLC2A1 was overexpressed in invasive ductal breast carcinoma and lobular breast carcinoma compared with that in the normal samples, with a fold change of 2.800 and 2.075 separately. This evidence concerns the gene SLC2A1 and invasive ductal breast carcinoma.